Develop, manufacture and market brand and generic pharmaceutical products utilizing various drug delivery technologies. Includes product data, career opportunities, and investor information. (NYSE: WPI)

Develops and manufactures slow-release adhesive patches for skin or oral cavity. Includes product range, news archive and contacts for investors in Miami, Florida. (Nasdaq: NOVN)

Researches and develops proprietary emulsions for lipophilic drugs, including formulations for cancer treatment. Outlines phase II studies, presentation and profile of company in Bothell, Washington. (Nasdaq: SNUS)

Develops and commercializes controlled-release products using proprietary polymer-based micropump microencapsulation technology. Headquartered in Venissieux, France.

Specialists in drug delivery and developing therapeutic products for human use, based in Kings College London.

A contract manufacturer of pharmaceutical and special-purpose tablets and hard gelatin capsules.

Develops and markets advanced controlled-release products for orally-administered drugs, and distributes generic pharmaceuticals. Includes brands, investor relations, and contacts throughout the USA. (Nasdaq: ADRX)

Develops and commercializes surfactant formulations for neonatal care, treatment of acute respiratory distress syndrome and lung injury. Information for patients, investors and careers in Doylestown, Pennsylvania. (Nasdaq: DSCO)

Develops and commercializes advanced dosage forms for controlled, predetermined rates of drug release, with a current emphasis in urology and oncology. Includes a description of products from Mountain View, California, United States. (NYSE: AZA).

Develops sustained-release injectables and inhalers for delivering drugs such as insulin. Includes product details, technology, investor news and contacts in Ohio and their headquarters in Cambridge, Massachusetts. (Nasdaq: ALKS)